Kevin Lee Taylor

Address:

3101 Clifton Ave, Baltimore, MD 21216

VIN:

JTDBT923X71088345

Make:

TOYOTA

Model:

YARIS

Year:

2007

US Patent:

6728885, Apr 27, 2004

Filed:

Oct 8, 1999

Appl. No.:

09/414711

Inventors:

Kevin R. Taylor - Ellicott City MD
Ganesh Murugesan - Reston VA
Homayoon Tajalli - Ellicott City MD

Assignee:

Networks Associates Technology, Inc. - Santa Clara CA

International Classification:

H04L 932

US Classification:

713201, 709238, 709249

Abstract:

A method, system and computer program for providing multilevel security to a computer network. The method comprises the step of receiving a first communication packet on at least one network interface port from an outside network. The method further includes the steps of filtering the first packet in one of at least two levels of security comprising a first level of security which examines the content information of the packet and a second level of security which examines the first packet excluding the content information of the packet. The system includes a first packet filter configured to filter its input packets by examining content information of its packets and a second packet filter configured to filter its input packets by examining the header information without examining the content information of its packets. The system further includes a third filter which is configured to forward a number of packets to one of the first and second filters, thereby providing security to the computer network. The computer program includes a first module located in an application layer, a second module located in a network layer, and a third module located in a kernel space and configured to examine a number of packets received by the computer network from at least one outside network and to forward the number of packets to one of the first and second modules after examining the number of packets.

US Patent:

7391770, Jun 24, 2008

Filed:

Jan 12, 2004

Appl. No.:

10/756687

Inventors:

Kevin R. Taylor - Ellicott City MD, US
Ganesh Murugesan - Silver Spring MD, US
Homayoon Tajalli - Ellicott City MD, US

Assignee:

McAfee, Inc. - Santa Clara CA

International Classification:

H04L 12/28

US Classification:

370389

Abstract:

A method, system and computer program for providing multilevel security to a computer network. The method comprises the step of receiving a first communication packet on at least one network interface port from an outside network. The method further includes the steps of filtering the first packet in one of at least two levels of security comprising a first level of security which examines the content information of the packet and a second level of security which examines the first packet excluding the content information of the packet. The system includes a first packet filter configured to filter its input packets by examining content information of its packets and a second packet filter configured to filter its input packets by examining the header information without examining the content information of its packets. The system further includes a third filter which is configured to forward a number of packets to one of the first and second filters, thereby providing security to the computer network. The computer program includes a first module located in an application layer, a second module located in a network layer, and a third module located in a kernel space and configured to examine a number of packets received by the computer network from at least one outside network and to forward the number of packets to one of the first and second modules after examining the number of packets.

US Patent:

20130246627, Sep 19, 2013

Filed:

Sep 14, 2007

Appl. No.:

11/855954

Inventors:

Kevin R. Taylor - Ellicott City MD, US
Ganesh Murugesan - Silver Spring MD, US
Homayoon Tajalli - Ellicott City MD, US

International Classification:

H04L 9/32
G06F 15/16

US Classification:

709227, 726 27

Abstract:

A method, system and computer program for providing multilevel security to a computer network. The method comprises the step of receiving a first communication packet on at least one network interface port from an outside network. The method further includes the steps of filtering the first packet in one of at least two levels of security comprising a first level of security which examines the content information of the packet and a second level of security which examines the first packet excluding the content information of the packet. The system includes a first packet filter configured to filter its input packets by examining content information of its packets and a second packet filter configured to filter its input packets by examining the header information without examining the content information of its packets. The system further includes a third filter which is configured to forward a number of packets to one of the first and second filters, thereby providing security to the computer network. The computer program includes a first module located in an application layer, a second module located in a network layer, and a third module located in a kernel space and configured to examine a number of packets received by the computer network from at least one outside network and to forward the number of packets to one of the first and second modules after examining the number of packets.

US Patent:

20220387095, Dec 8, 2022

Filed:

May 17, 2022

Appl. No.:

17/746361

Inventors:

- San Carlos CA, US
William S. Krimsky - Forest Hill MD, US
Seth S. Gleiman - Guilford CT, US
Nicholas S. Mercer - San Francisco CA, US
Timothy J. O'Brien - Santa Clara CA, US
Quim Castellvi - Barcelona, ES
Jonathan R. Waldstreicher - West Orange NJ, US
Kevin J. Taylor - San Mateo CA, US
Luis L. Mangual Arbelo - Sunnyvale CA, US

Assignee:

Galvanize Therapeutics, Inc. - San Carlos CA

International Classification:

A61B 18/14
A61P 37/04
A61P 35/00

Abstract:

Damaged, diseased, abnormal, obstructive, cancerous or undesired neural tissue treated by delivering specialized pulsed electric field (PEF) energy to target tissue areas. In some instances, the target tissue includes a tumor, a benign tumor, a malignant tumor, a cyst, or an area of diseased tissue. Most brain and spinal cord tumors develop from glial cells. These tumors are sometimes referred to as a group called gliomas. They arise from the supporting cells of the brain, called the glia. These cells are subdivided into astrocytes, ependymal cells and oligodendroglial cells (or oligos). One difficulty in the treatment of gliomas is that they are behind the blood-brain barrier (BBB) and blood-tumor barrier (BTB) which leads to poor delivery of anti-cancer drugs or immune agents to the tumor-infiltrated brain. Devices, systems and methods are provided that treat the tumor directly, such as by ablation, and optionally transiently disrupt the BBB coupled with adjuvant antibody, biologic, or other pharmaceutical interventions.

US Patent:

20230082389, Mar 16, 2023

Filed:

Sep 9, 2022

Appl. No.:

17/941815

Inventors:

- San Carlos CA, US
William Sanford Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US

Assignee:

Galvanize Therapeutics, Inc. - San Carlos CA

International Classification:

A61B 18/12
A61N 1/06

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

US Patent:

20210236815, Aug 5, 2021

Filed:

Mar 25, 2021

Appl. No.:

17/212833

Inventors:

- San Carlos CA, US
William S. Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US
Gary L. Long - Cincinnati OH, US

Assignee:

Galary, Inc. - San Carlos CA

International Classification:

A61N 1/32
A61N 1/05

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, those within the respiratory tract, particularly the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The systems may be used to treat pathogens, such as bacteria and viruses, particularly coronaviruses.

US Patent:

20210236816, Aug 5, 2021

Filed:

Mar 26, 2021

Appl. No.:

17/214688

Inventors:

- San Carlos CA, US
William Sanford Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US
Gary L. Long - Cincinnati OH, US

Assignee:

Galary, Inc. - San Carlos CA

International Classification:

A61N 1/32
A61N 1/06

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.

US Patent:

20210146126, May 20, 2021

Filed:

Jun 26, 2020

Appl. No.:

16/914072

Inventors:

- Menlo Park CA, US
William Sanford Krimsky - Forest Hill MD, US
Denise M. Zarins - Saratoga CA, US
Robert J. Beetel - Sunnyvale CA, US
Paul Brian Friedrichs - Belmont CA, US
Kevin James Taylor - San Mateo CA, US
Roman Turovskiy - San Francisco CA, US
Gary L. Long - Cincinnati OH, US

Assignee:

Galary, Inc. - Menlo Park CA

International Classification:

A61N 1/32
A61N 1/06

Abstract:

Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.